INVITATION TO INVESTOR MEETING


INVITATION TO INVESTOR MEETING

Stockholm, Sweden, August 26, 2008

Elekta is pleased to invite analysts and investors to an investor meeting held
in conjunction with the meeting of ASTRO (American Society for Therapeutic
Radiology and Oncology) in Boston, USA. 


Elekta will provide information about its current focus areas and product
portfolio. Elekta's President and CEO Tomas Puusepp, Dee Mathieson, SVP Business
Line Management Oncology Systems, and Jay Hoey, EVP Software Systems, will
participate in this meeting.  

Date and time: Monday September 22, from 2 p.m. to approximately 4 p.m. (EDT).

Location: Renaissance Boston Waterfront Hotel, Pacific Salon, 606 Congress
Street. This hotel is conveniently located across the street from the Boston
conference center. For more information, please see www.renaissanceboston.com.

Investors and analysts who want to attend this meeting are kindly requested to
give notice by e-mail to ir@elekta.com at the latest September 15. 

The meeting will be broadcasted over the Internet (audio and synchronized
slides). Please visit www.elekta.com - Investors, or use the direct link:
http://wcc.webeventservices.com/view/wl/r.htm?e=117622&s=1&k=E4C9ADAD664CF3DD6EA
2118DB5DE766A&cb=genesys

It will also be possible to listen to the meeting via telephone. It will however
not be possible to ask questions via the telephone conference. 

Call-in numbers for teleconference, September 22 at 2 p.m. EDT
UK:		+44 (0)20 7162 0025 
US:		+1 334 323 6201 
Norway:		+47 2156 31 20 
France:		+33 (0)1 7099 3208 
Germany:		+49 (0)695 8999 0507 
Netherlands:	+31 (0)20 7965 008 
Sweden:		+46 (0)8 5052 0110 
Denmark:		+45 3271 4607 
Switzerland (Geneva):	+41 (0)2 2592 7007 
Switzerland (Zurich):	+41 (0)434 5692 61

Please note that for local connect dial-in numbers it may be required to dial
the area code to enter the conference.

The telephone conference will be available afterwards on instant replay for
seven days. Please dial UK +44 (0)207 031 40 64, Sweden +46 (0) 8 505 203 33, US
+1 954 334 0342 and use access code 807653.


For further information, please contact:

Lena Schattauer, Investor Relations
Tel: +46 70 595 51 00 (mobile), e-mail: lena.schattauer@elekta.com  


About Elekta

Elekta is an international medical technology group, providing oncologists,
radiation therapists, neurosurgeons and many other medical specialists with
state of the art tools to fight serious disease.

Elekta provides advanced clinical solutions, comprehensive management and
information systems as well as services for improved cancer care and management
of brain disorders. 

Elekta's systems and solutions are used in over 5,000 hospitals around the
world. Clinical and information management solutions include, among others,
Leksell Gamma Knife® for non-invasive treatment of brain disorders, Elekta
Axesse™ and Elekta Synergy® for stereotactic and image guided radiation therapy
and radiosurgery as well as the MOSAIQ™ suite of software for image-enabled EMR
and efficient management of clinical and patient data.

With around 2,500 employees globally, the corporate headquarter is located in
Stockholm, Sweden and the company is listed on the Nordic Exchange under the
ticker EKTAb. More information about Elekta can be found at www.elekta.com.

Attachments

08262111.pdf